Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 81
A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
Anna Candoni, Gabriele Coppola
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 244-254
Open Access | Times Cited: 21
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
Warren Fiskus, Naval Daver, Steffen Boettcher, et al.
Leukemia (2022) Vol. 36, Iss. 11, pp. 2729-2733
Open Access | Times Cited: 51
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Yan Yi, Shenglei Ge
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 40
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Warren Fiskus, Christopher P. Mill, Christine Birdwell, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
KMT2C and KMT2D aberrations in breast cancer
Emily Tinsley, Philip Bredin, Sinéad Toomey, et al.
Trends in cancer (2024) Vol. 10, Iss. 6, pp. 519-530
Closed Access | Times Cited: 10
Menin Inhibitors: New Targeted Therapies for Specific Genetic Subtypes of Difficult-to-Treat Acute Leukemias
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 142-142
Open Access | Times Cited: 1
Synergistic effects of the KDM4C inhibitor SD70 and the menin inhibitor MI‐503 against MLL::AF9‐driven acute myeloid leukaemia
Wenqi Zhu, Yiyi Ding, Wanling Huang, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 2, pp. 568-579
Closed Access | Times Cited: 5
Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs
Qi-Li Liao, Jie Yang, Shengfang Ge, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 2, pp. 127-141
Open Access | Times Cited: 20
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Xin Li, Yuan Yao, Fangrui Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
Luisa Brock, Lina Benzien, Sandra Lange, et al.
Molecular Oncology (2025)
Open Access
A comprehensive high-throughput screening approach for discovering inhibitors targeting the menin-MLL1 interaction
Tamizhini Loganathan, C. George Priya Doss
Advances in protein chemistry and structural biology (2025), pp. 69-95
Closed Access
Histone–lysine N-methyltransferase 2 (KMT2) complexes – a new perspective
Elżbieta Poręba, Krzysztof Leśniewicz, Julia Durzyńska
Mutation Research/Reviews in Mutation Research (2022) Vol. 790, pp. 108443-108443
Open Access | Times Cited: 16
Therapeutic Targeting of the Menin–KMT2A Interaction
Pablo R. Freire, Jevon Cutler, Scott A. Armstrong
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 291-307
Closed Access | Times Cited: 3
Telomerase Inhibition in the Treatment of Leukemia: A Comprehensive Review
Elżbieta Bartoszewska, Klaudia Molik, Marta Woźniak, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 427-427
Open Access | Times Cited: 3
Diagnostic challenges in acute monoblastic/monocytic leukemia in children
Elena Varotto, Eleonora Munaretto, Francesca Stefanachi, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 15
Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML
Mika Caplan, Karli J. Wittorf, Kasidy Weber, et al.
Leukemia (2022) Vol. 36, Iss. 5, pp. 1296-1305
Open Access | Times Cited: 14
The engagement of histone lysine methyltransferases with nucleosomes: structural basis, regulatory mechanisms, and therapeutic implications
Yanjing Li, Kexue Ge, Tingting Li, et al.
Protein & Cell (2022)
Open Access | Times Cited: 13
Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins
Tian-Qi Chen, Heng‐Jing Huang, Shun-Xin Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1915-1915
Open Access | Times Cited: 2
COVID-19 vaccination and cancer immunotherapy: should they stick together?
Patrick Brest, Baharia Mograbi, Paul Hofman, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 1, pp. 1-3
Open Access | Times Cited: 17
Diverse modes of regulating methyltransferase activity by histone ubiquitination
James K. Fields, Chad W. Hicks, Cynthia Wolberger
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102649-102649
Open Access | Times Cited: 6
Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome
Aidin Foroutan, Sadegheh Haghshenas, Pratibha Bhai, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1815-1815
Open Access | Times Cited: 9
Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia
Andrew Matthews, Keith W. Pratz, Martin Carroll
Cancers (2022) Vol. 14, Iss. 23, pp. 5906-5906
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top